mRNA

© The Dna Universe/istockphoto/KJN

On the Dark Horse Podcast, Dr. Robert Malone, creator of mRNA vaccine applied science, said the COVID vaccine lipid nanoparticles — which tell the body to produce the spike protein — get out the injection site and accumulate in organs and tissues.

On June ten, Dr. Robert Malone, creator of mRNA vaccine technology, joined evolutionary biologist Bret Weinstein, Ph.D., for a 3-hour chat on the Dark Horse Podcast to hash out multiple safety concerns related to the Pfizer and Moderna vaccines.

In this brusk outtake from the full podcast, Malone, Weinstein and tech entrepreneur Steve Kirsch bear on the implications of the controversial Japanese Pfizer biodistribution study . The report was made public earlier this month by Dr. Byram Determent, a viral immunologist.

They also discuss the lack of proper creature studies for the new mRNA vaccines, and the theory , espoused by virologist Geert Vanden Bossche, Ph.D., that mass vaccination with the mRNA vaccines could produce e'er more than transmissible and potentially deadly variants.

Every bit The Defender reported June three, Bridle received a copy of a Japanese biodistribution report — which had been kept from the public — equally a result of a freedom of information request made to the Japanese government for Pfizer information.

Prior to the study'south disclosure, the public was led to believe past regulators and vaccine developers that the fasten poly peptide produced by mRNA COVID vaccines stayed in the shoulder where it was injected and was not biologically agile — fifty-fifty though regulators around the world had a re-create of the written report which showed otherwise.

The biodistribution study obtained past Bridle showed lipid nanoparticles from the vaccine did not stay in the deltoid musculus where they were injected every bit the vaccine's developers claimed would happen, but circulated throughout the body and accum ulated in large concentrations in organs and tissues, including the spleen, bone marrow, liver, adrenal glands and — in "quite high concentrations" — in the ovaries.

The mRNA — or messenger RNA — is what tells the torso to industry the spike protein. The lipid nanoparticles are like the "boxes" the mRNA is shipped in, co-ordinate to Malone. "If y'all find lipid nanoparticles in an organ or tissue, that tells you lot the drug got to that location," Malone explained.

Co-ordinate to the data in the Japanese study, lipid nanoparticles were found in the whole blood circulating throughout the body inside four hours, and then settled in large concentrations in the ovaries, bone marrow and lymph nodes.

Malone said in that location needed to be monitoring of vaccine recipients for leukemia and lymphomas every bit there were concentrations of lipid nanoparticles in the bone marrow and lymph nodes. But those signals often don't show up for half-dozen months to nine years down the road, he said.

Commonly, signals like this are picked up in animal studies and long-term clinical trials, but this didn't happen with mRNA vaccines, Malone said. There are two adverse result signals that are becoming apparent to the U.S. Food and Drug Administration (FDA). One of them is thrombocytopenia — not having enough platelets, which are manufactured in the bone marrow. The other is reactivation of latent viruses.

Malone found the ovarian signal perplexing considering there is no accumulation in the testes.

Malone said the original data packages contained this biodistribution information. "This information has been out there a long fourth dimension" within the protected, not-disclosed, purview of the regulators across the world, he said.

According to Malone, the FDA knew the COVID spike protein was biologically agile and could travel from the injection site and cause adverse events, and that the spike protein, if biologically agile, is very unsafe.

In fact, Malone was one of many scientists to warn the FDA about the dangers of the free spike protein.

Malone suggested autoimmune issues may be related to complimentary-circulating spike protein which developers assured would not happen. To choice upwardly autoimmune problems, a 2- to 3- year follow-upwardly period in phase 3 patients would be required to monitor for potential autoimmune consequences from vaccines — just that monitoring didn't happen with the Pfizer and Moderna vaccines.

Pfizer and Moderna too didn't conduct proper beast studies, Weinstein said. What the beast models give u.s.a. is a signal that alerts us to what we need to follow up on in humans. Weinstein said:

"We've got very alarming curt-term stuff. We've got short-term stuff that is alarming on the footing of where we detect these lipids, where nosotros find the fasten proteins — those things are reasons for concern because information technology wasn't supposed to be this manner. Nosotros've also got an alarming point in terms of the hazards and deaths or the harms and the deaths that are reported in the organisation and at that place are reasons to think they are dramatic nether-reports."

Vaden Bossche got it correct

I of the potential harms from the vaccines, Weinstein said, was made famous past Vanden Bossche, a vaccinologist who worked with GSK Biologicals, Novartis Vaccines, Solvay Biologicals, Bill & Melinda Gates Foundation's Global Wellness Discovery squad in Seattle, and Global Brotherhood for Vaccines and Immunization in Geneva.

Before this yr, Vanden Bossche put out a telephone call to the Globe Wellness Arrangement, supported by a 12-page document , that described the "uncontrollable monster" that a global mass vaccination entrada could potentially unleash.

Vanden Bossche said a combination of lockdowns, and extreme selection pressure level on the virus induced past the intense global mass vaccination program, might diminish the number of cases, hospitalizations and deaths in the short-term, simply ultimately, will induce the creation of more mutants of business organisation. This is what Vanden Bossche calls "immune escape" (i.e. incomplete sterilization of the virus by the human immune organisation, even post-obit vaccine assistants).

Immune escape will in turn trigger vaccine companies to farther refine vaccines that will add together, not reduce, the option pressure, producing always more than transmissible and potentially deadly variants.

The selection pressure will cause greater convergence in mutations that bear upon the critical fasten protein of the virus that is responsible for breaking through the mucosal surfaces of our airways, the route used by the virus to enter the human body.

The virus volition finer outsmart the highly specific antigen-based vaccines being used and tweaked, depending on the circulating variants. All of this could lead to a hockey stick-like increase in serious and potentially lethal cases — in effect, an out-of-control pandemic.

Malone said:

"Vanden Bossche's business organisation is not theoretical. It is real and nosotros have the information. We're stuck with this virus or its downstream variants pretty much for the residual of our lives and it'south going to become more like the influenza. We will take continuing evolution and circulation of variants, and that is an escape."